PAZOO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | -.--% |
Financials (USD)
| Sales 2016 | 30.52K | Sales 2017 | - | Capitalization | 395K |
|---|---|---|---|---|---|
| Net income 2016 | -8M | Net income 2017 | -3M | EV / Sales 2016 | 127 x |
| Net Debt 2016 | 3.44M | Net Debt 2017 | 3.05M | EV / Sales 2017 | - |
| P/E ratio 2016 |
-0.01
x | P/E ratio 2017 |
-0.03
x | Employees | 4 |
| Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 99.91% |
More Fundamentals
* Assessed data
More news
More press releases
Current year
0.00
0.00
1 year
0.000.00
3 years
0.000.00
5 years
0.000.00
10 years
0.001 625.00
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Basloe
CEO | Chief Executive Officer | 73 | - |
Ben Hoehn
DFI | Director of Finance/CFO | 43 | 11-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Steven Basloe
CEO | Chief Executive Officer | 73 | - |
Ben Hoehn
DFI | Director of Finance/CFO | 43 | 11-08-31 |
Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.69K | |
| -16.58% | 8.25B | |
| +40.93% | 3.58B | |
| -35.59% | 2.46B | |
| -7.88% | 2.46B | |
| -8.95% | 2.38B | |
| -5.93% | 1.81B | |
| -18.96% | 1.55B | |
| -38.35% | 1.21B | |
| +6.91% | 1.11B |
- Stock Market
- Equities
- PZOO Stock
